Fetal hydantoin syndrome
ICD-10 Q86.1 is a billable code used to indicate a diagnosis of fetal hydantoin syndrome.
Fetal hydantoin syndrome (FHS) is a congenital condition resulting from maternal exposure to the anticonvulsant medication phenytoin during pregnancy. This syndrome is characterized by a range of physical and developmental anomalies, including distinctive facial features such as a broad nasal bridge, a thin upper lip, and a smooth philtrum. Other common manifestations include growth deficiencies, microcephaly, and various congenital malformations affecting the heart, kidneys, and skeletal system. Children with FHS may also exhibit developmental delays and cognitive impairments. The severity of symptoms can vary widely among affected individuals, and early diagnosis and intervention are crucial for optimizing developmental outcomes. Management typically involves a multidisciplinary approach, including pediatricians, geneticists, and developmental specialists, to address the diverse needs of the child.
Pediatric documentation should include detailed growth and developmental assessments, family history, and any associated congenital anomalies.
Common scenarios include routine pediatric evaluations, referrals for developmental delays, and assessments for congenital anomalies.
Pediatric coders must ensure that all congenital anomalies are documented and coded accurately to reflect the child's condition.
Genetic documentation should include family history, genetic testing results, and any relevant chromosomal analysis.
Genetic counseling sessions for families with a history of anticonvulsant use during pregnancy and evaluations for genetic syndromes.
Genetic coders need to be aware of the implications of maternal medication exposure and its potential impact on genetic counseling.
Used for routine follow-up visits for children with congenital conditions.
Documentation must include history, examination, and medical decision-making.
Pediatricians should ensure that all aspects of the child's condition are addressed in the visit.
Key features of fetal hydantoin syndrome include distinctive facial features, growth deficiencies, and a range of congenital anomalies affecting various organ systems. Early diagnosis and intervention are crucial for improving outcomes.
